4
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73541 |
SYNTi
|
||
SYNTi 是一种针对 syndecan/syntenin 蛋白质-蛋白质相互作用的 PDZ 结构域抑制剂。 SYNTi 的 IC50值为 400 nM,配体效率 (LE) 值为 0.24。 SYNTi 可用于乳腺癌研究。 | |||
T82022 |
IVMT-Rx-3
|
NF-κB | NF-κB |
IVMT-Rx-3是针对SDCBP的PDZ1和PDZ2结构域,特别是MDA-9/Syntenin的抑制剂。该化合物能够中断MDA-9/Syntenin与Src之间的互动,减少NF-κB的激活,并且降低MMP-2/MMP-9的表达量,从而抑制了黑色素瘤的转移。 | |||
T63797 | PDZ1i | ||
PDZ1i 是有效的、能够透过血脑屏障的 MDA-9/Syntenin 特异性抑制剂。PDZ1i 能够抑制关键的 GBM (多形性成胶质细胞瘤)信号,包括 FAK 及 EGFRvIII,并能够减少 MMP 分泌。PDZ1i 可以提高患脑瘤小鼠的生存率并减少肿瘤的侵袭。 | |||
T83716 |
KSL-128114 TFA
Ac-rRrGrKkRrSHWX1X2DI-OH (X1=tert-Leucine; X2=Cyclohexylglycine) |
||
KSL-128114是一种对膜调节剂syntenin的肽抑制剂(Ki = 300 nM)。它能够依赖浓度降低A2058黑色素瘤和患者来源的多形性胶质母细胞瘤(GBM)细胞的存活率。在使用患者来源的GBM细胞并在颅内植入前用KSL-128114培养的患者衍生异种移植(PDX)小鼠模型中,KSL-128114(50 µM)提高了动物的存活时间。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04817 |
Syntenin Protein, Human, Recombinant (His)
MDA-9,SYCL,TACIP18,syndecan binding protein (syntenin |
Human | E. coli |
Syntenin1/SDCBP (syndecan binding protein), also known as melanoma differentiation associated gene-9 (MDA-9), is a PDZ domain-containing molecule, which was initially identified as a key oncogene in melanoma. IL-6 promotes glioma cell proliferation and invasion by inducing SDCBP expression, which is mediated by JAK2/STAT3 signaling. SDCBP might be an important marker for identifying Triple negative breast cancer (TNBC) cases that are suitable for dasatinib therapy. |